BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33374979)

  • 1. Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders.
    Panzarini E; Mariano S; Tacconi S; Carata E; Tata AM; Dini L
    Nanomaterials (Basel); 2020 Dec; 11(1):. PubMed ID: 33374979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of curcumin nanodelivery on schizophrenia and glioblastoma.
    Bulnes S; Picó-Gallardo M; Bengoetxea H; Lafuente JV
    Int Rev Neurobiol; 2023; 171():163-203. PubMed ID: 37783555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment.
    Godse S; Zhou L; Sakshi S; Singla B; Singh UP; Kumar S
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2151-2166. PubMed ID: 38058006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review.
    Hani U; Shivakumar HG
    Curr Drug Deliv; 2014; 11(6):792-804. PubMed ID: 25176028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocurcumin: A Double-Edged Sword for Microcancers.
    Janjua KA; Shehzad A; Shahzad R; Islam SU; Islam MU
    Curr Pharm Des; 2020; 26(45):5783-5792. PubMed ID: 33213321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conundrum and therapeutic potential of curcumin in drug delivery.
    Kumar A; Ahuja A; Ali J; Baboota S
    Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The theranostic potentialities of bioavailable nanocurcumin in oral cancer management.
    Essawy MM; Mohamed MM; Raslan HS; Rafik ST; Awaad AK; Ramadan OR
    BMC Complement Med Ther; 2022 Nov; 22(1):309. PubMed ID: 36424593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional polymeric nanocurcumin for cancer therapy.
    Shehzad A; Ul-Islam M; Wahid F; Lee YS
    J Nanosci Nanotechnol; 2014 Jan; 14(1):803-14. PubMed ID: 24730299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocurcumin: a promising therapeutic advancement over native curcumin.
    Flora G; Gupta D; Tiwari A
    Crit Rev Ther Drug Carrier Syst; 2013; 30(4):331-68. PubMed ID: 23662605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
    Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases.
    Rahiman N; Markina YV; Kesharwani P; Johnston TP; Sahebkar A
    J Control Release; 2022 Aug; 348():264-286. PubMed ID: 35649486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Curcumin Bioavailability by Encapsulation in Sophorolipid-Coated Nanoparticles: An in Vitro and in Vivo Study.
    Peng S; Li Z; Zou L; Liu W; Liu C; McClements DJ
    J Agric Food Chem; 2018 Feb; 66(6):1488-1497. PubMed ID: 29378117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles and blood-brain barrier: the key to central nervous system diseases.
    Domínguez A; Suárez-Merino B; Goñi-de-Cerio F
    J Nanosci Nanotechnol; 2014 Jan; 14(1):766-79. PubMed ID: 24730296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
    Lungare S; Hallam K; Badhan RK
    Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
    Kharat M; McClements DJ
    J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodelivery of phytobioactive compounds for treating aging-associated disorders.
    Lushchak O; Strilbytska O; Koliada A; Zayachkivska A; Burdyliuk N; Yurkevych I; Storey KB; Vaiserman A
    Geroscience; 2020 Feb; 42(1):117-139. PubMed ID: 31686375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks.
    Zhang Y; Rauf Khan A; Fu M; Zhai Y; Ji J; Bobrovskaya L; Zhai G
    J Drug Target; 2019 Nov; 27(9):917-931. PubMed ID: 30672353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead Exposure in Different Organs of Mammals and Prevention by Curcumin-Nanocurcumin: a Review.
    Pal M; Sachdeva M; Gupta N; Mishra P; Yadav M; Tiwari A
    Biol Trace Elem Res; 2015 Dec; 168(2):380-91. PubMed ID: 26005056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin Cocrystal Micelles-Multifunctional Nanocomposites for Management of Neurodegenerative Ailments.
    Desai PP; Patravale VB
    J Pharm Sci; 2018 Apr; 107(4):1143-1156. PubMed ID: 29183742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.